Raymond James Financial Inc. Takes Position in Genpact Limited (NYSE:G)

Raymond James Financial Inc. purchased a new stake in Genpact Limited (NYSE:G - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 129,261 shares of the business services provider's stock, valued at approximately $5,552,000. Raymond James Financial Inc. owned 0.07% of Genpact at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in G. SRH Advisors LLC bought a new position in Genpact in the 4th quarter valued at about $26,000. Manchester Capital Management LLC acquired a new stake in shares of Genpact in the 4th quarter worth approximately $38,000. Smartleaf Asset Management LLC boosted its holdings in shares of Genpact by 416.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after acquiring an additional 783 shares in the last quarter. UMB Bank n.a. increased its stake in shares of Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after acquiring an additional 433 shares during the period. Finally, J.Safra Asset Management Corp raised its holdings in Genpact by 38.8% during the fourth quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider's stock worth $69,000 after purchasing an additional 453 shares in the last quarter. Institutional investors own 96.03% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price target for the company from $44.00 to $55.00 in a report on Tuesday, January 21st. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and upped their price target for the company from $45.00 to $60.00 in a report on Friday, February 7th. Needham & Company LLC raised their price objective on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Finally, Mizuho lifted their target price on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $48.44.

Insider Buying and Selling

In other Genpact news, SVP Piyush Mehta sold 12,000 shares of the business's stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares of the company's stock, valued at $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. This represents a 4.20 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is owned by corporate insiders.

Genpact Stock Down 1.5 %

Genpact stock traded down $0.75 during mid-day trading on Friday, hitting $50.00. The company's stock had a trading volume of 1,088,529 shares, compared to its average volume of 1,358,206. Genpact Limited has a 52-week low of $30.23 and a 52-week high of $56.76. The company has a market cap of $8.78 billion, a PE ratio of 17.61, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The firm's 50 day moving average is $50.74 and its 200 day moving average is $44.94.

Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. On average, analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were paid a $0.17 dividend. The ex-dividend date was Tuesday, March 11th. This is an increase from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.36%. Genpact's dividend payout ratio is 23.94%.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.